CHATBOTS IN CLINICAL TRIALS: IMPROVING PATIENT ENGAGEMENT
*Meesa Kalyani and Bathula Manuja
ABSTRACT
Clinical trials serve as vital tools in enhancing our understanding of the effectiveness of new treatments across various diseases, including cancers. Despite their importance, studies reveal that less than 5% of cancer patients engage in any form of research study or clinical trial. This low participation rate can be attributed to diverse factors. To address this issue, we propose an innovative solution: the implementation of a Chatbot. This Chatbot is designed to foster interactive, two-way communication with users, aiding them in assessing their eligibility for clinical trials. By providing a user-friendly interface for individuals to explore their potential participation in research studies, the Chatbot aims to overcome barriers and promote greater engagement in clinical trials.
Keywords: Clinical trials, cancer research, patient participation, eligibility assessment, Chatbot, interactive communication, research study engagement.
[Full Text Article]
[Download Certificate]